Debt

6 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Debt

6. Debt

Long-term debt consists of the following.

(in thousands)	June 30, 2023		December 31, 2022
Fixed rate mortgage notes payable due 2024 through 2047; weighted average interest rate of 4.14% as of both June 30, 2023 and December 31, 2022	$	2,045,952	$	2,055,867
Variable rate mortgage notes payable due 2025 through 2030; weighted average interest rate of 7.50% and 6.68% as of June 30, 2023 and December 31, 2022, respectively	1,532,286		1,568,555
Convertible notes payable due October 2026; interest rate of 2.00% as of both June 30, 2023 and December 31, 2022	230,000		230,000
Tangible equity units senior amortizing notes due November 2025; interest rate of 10.25% as of both June 30, 2023 and December 31, 2022	21,946		25,586
Other notes payable due 2023; interest rate of 5.90% as of June 30, 2023	10,416		—
Deferred financing costs, net	(26,311)		(29,866)
Total long-term debt	3,814,289		3,850,142
Current portion	53,729		66,043
Total long-term debt, less current portion	$	3,760,560	$	3,784,099

As of June 30, 2023, 91.8%, or $3.5 billion, of the Company's total debt obligations represented non-recourse property-level mortgage financings.

As of June 30, 2023, $1.2 billion of the Company's variable rate mortgage notes payable were indexed to LIBOR plus a weighted average margin of approximately 228 basis points and $0.3 billion of the Company's variable rate mortgage notes payable were indexed to SOFR plus a weighted average margin of approximately 237 basis points. The Company's remaining variable rate mortgage notes payable arrangements indexed to LIBOR were modified to reference SOFR plus an 11 basis point spread adjustment to reflect historical spreads between LIBOR and SOFR rather than LIBOR prospectively after the discontinuance of LIBOR in July 2023. The Company applied the optional expedient provided by Accounting Standards Codification 848, Reference Rate Reform, for debt contract modifications related to the discontinuation of reference rates to ease the potential burden in accounting for reference rate reform.

As of June 30, 2023, $72.6 million of letters of credit and no cash borrowings were outstanding under the Company's $80.0 million secured credit facility. The credit facility matures on January 15, 2024 and the Company has the option to extend the facility for two additional terms of one year each subject to the satisfaction of certain conditions. The Company also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of June 30, 2023 under which $14.5 million had been issued as of that date.

Financial Covenants

Certain of the Company's debt documents contain restrictions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and debt service ratios, and requiring the Company not to exceed prescribed leverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community, and/or entity basis. In addition, the Company's debt documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable debt documents. Many of the Company's debt documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Furthermore, the Company's long-term mortgage debt is secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of June 30, 2023, the Company is in compliance with the financial covenants of its debt agreements.